Startups channel feed

Cana­di­an biotech VC Am­pli­tude rais­es $192M sec­ond fund

12 months ago
Financing

Gilead forms pact with Car­tog­ra­phy to map new tar­gets for can­cer drugs

12 months ago
Deals
Pharma

BioN­Tech dou­bles down on ADC part­ner MediLink in new $1.8B biobucks pact

12 months ago
Deals
China

UK biotech re­vives for­mer Ky­owa Kirin can­cer drug for Ep­stein-Barr-dri­ven dis­eases

Last year
R&D

Grey Wolf reels in $50M to ex­pand in­to au­toim­mune dis­eases

Last year
Financing

Take­da en­ters hot mol­e­c­u­lar glue space in up to $1.2B pact with De­gron

Last year
China
Pharma

Twin Health ex­pands in­to treat­ing obe­si­ty with dig­i­tal twins

Last year
Health Tech

Ver­sant has a new obe­si­ty biotech. As­traZeneca has the op­tion to buy it

Last year
Financing
Pharma

Al­tru­Bio se­cures $225M for an up­dat­ed ver­sion of its ul­cer­a­tive col­i­tis drug

Last year
Financing

Lil­ly makes an­oth­er ra­dio­phar­ma move in col­lab­o­ra­tion with Ak­tis On­col­o­gy

Last year
Deals

ADC biotech Pheon rais­es $120M to test three as­sets in the clin­ic

Last year
Financing

Prog­en­tos emerges with $65M for mul­ti­ple scle­ro­sis tri­als with IP from Fre­quen­cy

Last year
Financing

Health plan start­up Cen­ti­vo ac­quires pri­ma­ry care op­er­a­tor Eden Health

Last year
Deals
Health Tech

Rap­port, a clin­i­cal-stage neu­ro­science biotech, files for IPO

Last year
Financing

Bain, At­las, RTW back new biotech de­vel­op­ing obe­si­ty drugs with $400M

Last year
China

Up­dat­ed: Sands Cap­i­tal rais­es $555M for third life sci­ences fund

Last year
Financing

Car­olyn Bertozzi-found­ed Ly­cia Ther­a­peu­tics rais­es $106M to en­ter the clin­ic

Last year
Financing

'At­tack JAK': Ajax se­cures $95M to test new JAK2 in­hibitor af­ter in­dus­try's string of myelofi­bro­sis deals

Last year
Financing

Sci­en­tists and star­tups re­veal new gene in­ser­tion tech­niques, though much re­mains be­hind closed doors: #AS­GCT24

Last year
R&D
Cell/Gene Tx

Ace­lyrin's found­ing CEO steps down, com­pa­ny scraps earn­ings call

Last year
People

In­fec­tious dis­ease biotech Blue­jay rais­es $182M for he­pati­tis tri­als

Last year
Financing

At­tovia reels in $105M from crossover in­vestors to run mul­ti­ple tri­als of I&I bi­o­log­ics

Last year
Financing

No­vo Nordisk sees more to GLP-1's fu­ture in $600M pact with Flag­ship's Metaphore

Last year
Deals

Aard­vark nabs $85M to tar­get hunger, not ap­petite, as it eyes 2026 NDA fil­ing

Last year
Financing
First page Previous page 15161718192021 Next page Last page
A service from the Financial Times